Compare Acset Indonusa Tbk (ACST) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acset Indonusa Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Acset Indonusa Tbk trades at Rp87 (market cap 1.52T, 161.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Acset Indonusa Tbk is far larger — about 9.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 161.8K). Which is the better fit depends on your goals.
| ACST | OBAT | |
|---|---|---|
Market Cap | 1.52T | 164.65B |
Volume | 161.8K | 187.4K |
Lot | 1.62K | 1.87K |
Turnover | 14.08M | 44.35M |
Average Price | 87.04 | 236.67 |
Value | 14.08M | 44.35M |
Indicative Equilibrium Price | 87 | 242 |
Indicative Equilibrium Volume | 744 | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acset Indonusa Tbk
PT Acset Indonusa Tbk (the Company) was establised based on Notarial Deed No.2 dated January 10, 1995 of Ny. Liliana Arif Gondoutomo, S.H., Notary in Bekasi.
Read more on ACST →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
